Biotech · Private company
MEDA Pharma GmbH & Co. KG
Track this companyFree. Adds MEDA Pharma GmbH & Co. KG to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs7From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline7
- PimecrolimusPhase 3 · Atopic DermatitisClinicalTrials.gov · fetched Nov 12, 2026
- Thioctic AcidPhase 3 · Diabetic PolyneuropathyClinicalTrials.gov · fetched Nov 12, 2026
- Topical corticosteroidsPhase 3 · Atopic DermatitisClinicalTrials.gov · fetched Nov 12, 2026
- Foradil P 12µgPhase 2 · AsthmaClinicalTrials.gov · fetched Nov 12, 2026
- Foradil P 24µgPhase 2 · AsthmaClinicalTrials.gov · fetched Nov 12, 2026
- Formatris 12µgPhase 2 · AsthmaClinicalTrials.gov · fetched Nov 12, 2026
- Formatris 24µgPhase 2 · AsthmaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Relative Potency of Formoterol Novolizer® 12 µg Compared to Formoterol Aerolizer® 12 µgPHASE2 · COMPLETED · started Dec 1, 2010ClinicalTrials.gov NCT01256086 · fetched Nov 12, 2026
- 5-Year Safety Study of Pimecrolimus Cream 1% in Infants 3 - 12 Months of Age With Mild to Moderate Atopic DermatitisPHASE3 · COMPLETED · started Apr 1, 2004ClinicalTrials.gov NCT00120523 · fetched Nov 12, 2026
- Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2)PHASE3 · COMPLETED · started May 1, 1998ClinicalTrials.gov NCT00977483 · fetched Nov 12, 2026